Prognostic Value of Metabolic, Volumetric and Textural Parameters of Baseline [
TNBC
[18F]FDG PET/CT
prognosis
textural features
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
27 Jan 2022
27 Jan 2022
Historique:
received:
04
12
2021
revised:
22
01
2022
accepted:
23
01
2022
entrez:
15
2
2022
pubmed:
16
2
2022
medline:
16
2
2022
Statut:
epublish
Résumé
(1) Background: triple-negative breast cancer (TNBC) remains a clinical and therapeutic challenge primarily affecting young women with poor prognosis. TNBC is currently treated as a single entity but presents a very diverse profile in terms of prognosis and response to treatment. Positron emission tomography/computed tomography (PET/CT) with
Identifiants
pubmed: 35158904
pii: cancers14030637
doi: 10.3390/cancers14030637
pmc: PMC8833829
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Eur J Nucl Med Mol Imaging. 2015 Oct;42(11):1682-1691
pubmed: 26140849
Breast Cancer Res. 2019 May 17;21(1):65
pubmed: 31101122
J Clin Oncol. 2006 Dec 20;24(36):5652-7
pubmed: 17116942
Nucl Med Mol Imaging. 2018 Jun;52(3):170-189
pubmed: 29942396
Breast Cancer Res. 2015 Mar 20;17:43
pubmed: 25887482
J BUON. 2015 Sep-Oct;20(5):1282-6
pubmed: 26537076
Eur J Nucl Med Mol Imaging. 2012 Dec;39(12):1830-8
pubmed: 22895862
Eur J Nucl Med Mol Imaging. 2019 Jul;46(7):1468-1477
pubmed: 30915523
Eur J Nucl Med Mol Imaging. 2015 Aug;42(9):1371-7
pubmed: 25947575
Eur J Nucl Med Mol Imaging. 2022 Jan;49(2):550-562
pubmed: 34328530
J Nucl Med. 2016 Nov;57(11):1823-1828
pubmed: 27261515
BMC Cancer. 2018 Jan 8;18(1):56
pubmed: 29310602
Sci Rep. 2018 Aug 8;8(1):11859
pubmed: 30089896
Cancers (Basel). 2021 Mar 12;13(6):
pubmed: 33809057
Breast. 2013 Oct;22(5):958-63
pubmed: 23756383
Biostatistics. 2007 Jan;8(1):118-27
pubmed: 16632515
Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):831-837
pubmed: 30648199
Head Neck. 2019 Feb;41(2):495-502
pubmed: 30549149
PLoS One. 2014 Apr 10;9(4):e94017
pubmed: 24722644
Eur J Nucl Med Mol Imaging. 2017 Oct;44(11):1787-1795
pubmed: 28616695
Nuklearmedizin. 2020 Jun;59(3):228-234
pubmed: 32259852
Ann Oncol. 2014 Aug;25(8):1544-50
pubmed: 24608200
AJR Am J Roentgenol. 2017 Sep;209(3):662-670
pubmed: 28678576
Clin Cancer Res. 2007 Apr 15;13(8):2329-34
pubmed: 17438091
Ann Nucl Med. 2018 Jul;32(6):379-388
pubmed: 29869770
Ann Nucl Med. 2017 Aug;31(7):544-552
pubmed: 28646331
Ann Oncol. 2013 Sep;24(9):2206-23
pubmed: 23917950
Laryngoscope. 2017 Jan;127(1):E22-E28
pubmed: 27435352
J Clin Oncol. 2012 May 20;30(15):1796-804
pubmed: 22508812
Eur J Nucl Med Mol Imaging. 2018 Feb;45(2):196-206
pubmed: 28936601
Mol Imaging Biol. 2019 Aug;21(4):771-780
pubmed: 30397859
Breast Cancer Res. 2017 Jan 5;19(1):3
pubmed: 28057031
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
PLoS One. 2016 Jun 16;11(6):e0157368
pubmed: 27310713
Clin Cancer Res. 2015 Apr 1;21(7):1688-98
pubmed: 25208879
PLoS One. 2019 Dec 11;14(12):e0225959
pubmed: 31826010
Bioinformatics. 2013 Nov 15;29(22):2877-83
pubmed: 23958724
Breast Cancer Res Treat. 2016 Jul;158(2):323-31
pubmed: 27372069
Cancer. 2007 Aug 15;110(4):876-84
pubmed: 17620276
Proteomics. 2019 Nov;19(21-22):e1800484
pubmed: 30951236
Sci Rep. 2019 Jul 29;9(1):10946
pubmed: 31358786
Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4429-34
pubmed: 17671126
Eur J Nucl Med Mol Imaging. 2015 Mar;42(3):419-28
pubmed: 25339524
J Nucl Med. 2014 Jun;55(6):891-7
pubmed: 24752672
Eur Radiol. 2015 Nov;25(11):3314-21
pubmed: 25903708
Int J Clin Oncol. 2010 Dec;15(6):588-93
pubmed: 20809217
J Nucl Med. 2014 Mar;55(3):414-22
pubmed: 24549286
Clin Nucl Med. 2019 Jan;44(1):21-29
pubmed: 30394924
J Nucl Med. 2005 Aug;46(8):1342-8
pubmed: 16085592
Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):412-422
pubmed: 29192365
Nucl Med Commun. 2018 Jan;39(1):83-93
pubmed: 29135722
Nucl Med Commun. 2020 Aug;41(8):824-829
pubmed: 32516244
Eur J Cancer. 2012 Mar;48(4):441-6
pubmed: 22257792
Rev Esp Med Nucl Imagen Mol. 2016 Nov - Dec;35(6):365-372
pubmed: 26948652
Eur J Nucl Med Mol Imaging. 2020 May;47(5):1116-1126
pubmed: 31982990
Bull Cancer. 2019 Mar;106(3):262-274
pubmed: 30683308
J Nucl Med. 2019 May;60(5):600-607
pubmed: 30389824
Nucl Med Commun. 2015 Jan;36(1):28-37
pubmed: 25299471
Radiology. 2016 Jan;278(1):214-22
pubmed: 26176655
Nucl Med Commun. 2018 Jul;39(7):680-690
pubmed: 29893750
J Nucl Med. 2017 Mar;58(3):365-366
pubmed: 27811126
Breast Cancer Res Treat. 2015 Oct;153(3):607-16
pubmed: 26346756
Bioinformatics. 2008 May 1;24(9):1154-60
pubmed: 18325927
Lancet. 2014 Jul 12;384(9938):164-72
pubmed: 24529560
Phys Med Biol. 2017 Jul 7;62(13):5327-5343
pubmed: 28604368
Radiother Oncol. 2020 Mar;144:72-78
pubmed: 31733491
Indian J Nucl Med. 2019 Jan-Mar;34(1):10-13
pubmed: 30713371
Eur J Nucl Med Mol Imaging. 2016 Jul;43(8):1453-60
pubmed: 26830299
N Engl J Med. 2017 Jun 1;376(22):2147-2159
pubmed: 28564564
Eur J Nucl Med Mol Imaging. 2017 Feb;44(2):206-214
pubmed: 27613542
Cancers (Basel). 2021 Jun 11;13(12):
pubmed: 34208197
J Nucl Med. 2017 Mar;58(3):387-392
pubmed: 27754906
Eur J Nucl Med Mol Imaging. 2017 Aug;44(9):1438-1447
pubmed: 28488029
Mol Oncol. 2011 Feb;5(1):5-23
pubmed: 21147047
Eur Radiol. 2014 Mar;24(3):610-8
pubmed: 24097303
J Clin Oncol. 2008 Mar 10;26(8):1275-81
pubmed: 18250347
Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):738-46
pubmed: 24064322
J Clin Invest. 2011 Jul;121(7):2750-67
pubmed: 21633166
J Clin Oncol. 2007 Nov 1;25(31):4952-60
pubmed: 17971593